Form 4: NHI Director Jobe Exercises Options, Adjusts Holdings
Insider Transaction Report
National Health Investors Director James R. Jobe reported exercising stock options and subsequent sales of common stock, adjusting his beneficial ownership.
Summary
- Director James R. Jobe exercised 10,000 stock options for National Health Investors Inc. (NHI) common stock at a price of $73.34 per share on February 17, 2026.
- Following the option exercise, Jobe disposed of 8,058 shares of common stock at $91.02 per share on the same date, likely to cover exercise costs or tax obligations.
- An additional 500 shares of common stock held in an IRA SEP account were disposed of on February 17, 2026.
- After these transactions, Jobe's direct beneficial ownership of common stock jointly held with his spouse is 33,497 shares.
- The IRA SEP account now holds 0 shares following the disposition.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, typical for insider option exercises where a portion of shares are sold to cover costs and taxes, without a clear positive or negative signal for the company's future.
Positives
- Director Jobe exercised stock options at $73.34, which is below the market price of $91.02 at which some shares were disposed, indicating a profitable transaction for the insider.
Negatives
- Director Jobe disposed of 8,058 shares at $91.02 and an additional 500 shares from an IRA SEP, resulting in a net reduction of his overall direct beneficial ownership of common stock.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that insider transactions, particularly option exercises followed by sales to cover costs or taxes, are common events in the REIT sector, often driven by personal financial planning rather than a direct signal about the company's future performance.
Stakeholder Impact
- Shareholders: The net effect of the transactions is a reduction in the director's direct beneficial ownership. While the exercise itself is neutral, the subsequent sale, even for tax purposes, slightly reduces insider alignment. However, this is a common practice and generally not a significant concern.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date stock options became exercisable. |
| 02/17/2026 | Date of option exercise and stock dispositions. |
| 02/18/2026 | Date the Form 4 filing was signed. |
| 03/03/2030 | Stock option expiration date. |
Recommendation
holdThis Form 4 filing details a routine insider transaction involving the exercise of stock options and subsequent sale of shares, likely for tax purposes. Such transactions are common and generally do not provide a strong signal for future stock performance, thus a 'hold' recommendation is appropriate as it doesn't fundamentally alter the investment thesis for NHI.
Keywords
NHI, National Health Investors, insider trading, Form 4, stock options, director, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.